Screener
Organogenesis Holdings Inc. ORGO Total Cost of Revenue
Discontinued — last reported Q1 '25
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed May 8, 2025.
- Filed
- May 8, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0000950170-25-066962
| Line item | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 |
|---|---|---|
| Net revenue | $86,693 | $109,976 |
| Cost of goods sold | 23,723 | 28,696 |
| Gross profit | 62,970 | 81,280 |
| Operating expenses: | ||
| Selling, general and administrative | 72,509 | 72,322 |
| Research and development | 10,640 | 12,810 |
| Write-down to fair value for asset held for sale | 6,567 | — |
| Total operating expenses | 89,716 | 85,132 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s total cost of revenue?
- Organogenesis Holdings Inc. (ORGO) reported total cost of revenue of $23.72M in Q1 2025.
- How has Organogenesis Holdings Inc.'s total cost of revenue changed year-over-year?
- Organogenesis Holdings Inc.'s total cost of revenue decreased by 17.3% year-over-year, from $28.7M to $23.72M.
- What is the long-term trend for Organogenesis Holdings Inc.'s total cost of revenue?
- Over 3 years (2021 to 2024), Organogenesis Holdings Inc.'s total cost of revenue has grown at a 0.4% compound annual growth rate (CAGR), from $114.2M to $115.74M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Organogenesis Holdings Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude